Maternal and fetal platelet activation in normal pregnancy

Umberto Nicolini, Daniela Guarneri, Gian Angelo Gianotti, Cesare Campagnoli, Pier Giorgio Crosignani, Loredana Gatti

Research output: Contribution to journalArticle

Abstract

Objective: To study the platelet activation phase in normal pregnant women and their fetuses, both in vivo under basal conditions and in vitro after stimulation by adenosine diphosphate (ADP), a weak agonist, and U46619, a strong one. Methods: Platelet function was investigated in 39 normal pregnant women and their fetuses undergoing fetal blood sampling at 18–37 weeks’ gestation, using flow cytometry and the anti-GMP140 monoclonal antibody. This combined technique allows platelets to be investigated in small aliquots of whole blood, and it detects platelet secretion regardless of aggregation. In all cases, the percentage of activated platelets was determined under basal conditions and after addition of platelet agonists: ADP at concentrations of 10 and 50 μmol/L, and U46619, a stable analogue of thromboxane A2, at 1 μmol/L. Results: Compared to nonpregnant controls, pregnant women had a significantly lower percentage of activated platelets after addition of U46619 (P = .02). Compared to their mothers, fetuses had significantly inferior platelet activation after addition of both platelet-activating factors at all concentrations used (ADP 10 μmol/L, P <.0001 and ADP 50 μmol/L, P <.0001; U46619, P <.0001). Maternal and fetal platelet activation did not change with duration of gestation. In the fetus, the percentage of activated platelets did not correlate with hematocrit, pH, or oxygen pressure, but it correlated significantly with platelet count after addition of U46619 (r = 0.45, P = .006). Conclusions: Decreased platelet activation in both pregnant women and fetuses suggests the action of a plasma factor that selectively inhibits prostaglandin-dependent activation. Prostacyclin, which is known to decrease platelet aggregation and release reactions caused by agonists, might have a greater inhibitory effect in the fetus than in the mother, or be present in larger amounts in the fetus.

Original languageEnglish
Pages (from-to)65-69
Number of pages5
JournalObstetrics and Gynecology
Volume83
Issue number1
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Maternal and fetal platelet activation in normal pregnancy'. Together they form a unique fingerprint.

  • Cite this

    Nicolini, U., Guarneri, D., Gianotti, G. A., Campagnoli, C., Crosignani, P. G., & Gatti, L. (1994). Maternal and fetal platelet activation in normal pregnancy. Obstetrics and Gynecology, 83(1), 65-69.